Optimization of entrapment of metronidazole in amphiphilic β-cyclodextrin nanospheres

Journal of Pharmaceutical and Biomedical Analysis

Volumn 41, Issue 3, 2006, Pages 1017-1021

  Lahiani Skiba, Malika ^a   Bounoure, Frederic ^a   Shawky Tous, Sozan ^b   Arnaud, P ^a   Skiba, Mohamed ^a  

^a Faculté de Médecine Pharmacie   (France)

^b Assiut University   (Egypt)

Author keywords

Amphiphilic cyclodextrin; Metronidazole; Nanosphere suspension

Indexed keywords

ACETONE; AMPHOPHILE; BETA CYCLODEXTRIN; METRONIDAZOLE; NANOCRYSTAL; NANOPARTICLE; POLOXAMER; SURFACTANT; ANTIPROTOZOAL AGENT; BETA CYCLODEXTRIN DERIVATIVE;

ACTIVE TRANSPORT; AQUEOUS SOLUTION; ARTICLE; CRYSTALLIZATION; DRUG EFFICACY; DRUG FORMULATION; ENCAPSULATION; LIVER ABSCESS; PARTICLE SIZE; PRIORITY JOURNAL; CHEMISTRY; NANOTECHNOLOGY;

ANTIPROTOZOAL AGENTS; BETA-CYCLODEXTRINS; METRONIDAZOLE; NANOTECHNOLOGY; PARTICLE SIZE; SURFACE-ACTIVE AGENTS;

EID: 33746528231     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.01.021     Document Type: Article

References (14)

1. Freeman C.D., Klutman N.E., and Lamp K.C. Drugs 54 (1997) 679-708
2. Skiba M., Morvan C., Duchêne D., Puisieux F., and Wouessidjewe D. Int. J. Pharm. 126 (1995) 275-279
3. Memisoglu E., Vural I., Guç D., Dogan L., and Hincal A.A. Eur. J. Pharm. Sci. 17 (2002) S81-S82
4. M. Skiba, D. Wouessidjewe, A.W. Coleman, H. Fessi, J.-P. Devissaguet, D. Duchêne, F. Puisieux, PCT applications FR 93/00594, 1993.
5. Memisoglu E., Bochot A., Ozalp M., Duchene D., and Hincal A.A. Pharm. Res. 20 (2003) 117-125
6. Skiba M., Wouessidjewe D., Puisieux F., Duchêne D., and Gulik A. Int. J. Pharm. 142 (1996) 121-124
7. Skiba M., Duchêne D., Puisieux F., and Wouessidjewe D. Int. J. Pharm. 129 (1996) 113-121
8. Gulik A., Delacroix H., Wouessidjewe D., and Skiba M. Langmuir 14 (1998) 1050-1057
9. Ringard-Lebvre C., Bochot A., Memisoglu E., and Charon D. Coll. Surf. B Biointerfaces 25 (2002) 109-117
10. Zhang P., Ling C.C., Coleman A.W., Parrot-Lopez H., and Galons H. Tetrahedron Lett. 32 (1991) 2769-2770
11. Ferreira L.A.M., Seiller M., Grossiord J.L., Marty J.P., and Wepierre J. Int. J. Pharm. 109 (1994) 251-259
12. I.A. Hadi, M. Kata, K. Pintye-Hodi, F. Giordano, G. Bruni, M. Rillosi, A. Gazzaniga, Proceedings of the Sixth International Conference on Pharmaceutical Technology, vol. V, Paris, 2-4 June 1992, pp. 401-407.
13. Memisoglu E., Bochot A., Duchene M.D., and Hincal A.A. Int. J. Pharm. 251 (2003) 143-153
14. Labhasetwar V.D., and Dorle A.K. J. Control. Release 12 (1990) 113-119